U.S. Markets open in 17 hrs, 28 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,449.96 | 131.80 | 1.28% |
| NASDAQ | 2,176.01 | 29.97 | 1.40% |
| S&P 500 | 1,106.16 | 14.78 | 1.35% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 8.41 09:30 AM EST | |
|---|---|---|
| Day High | 8.8199 09:40 AM EST |
|
| Range | 0.41 |
| Volume | 547,044 | |
|---|---|---|
| 30-Day Avg Vol | 489,000 |
|
| Difference | 11.87% |
| Market Cap | 488.41 M | |
|---|---|---|
| Mkt Cap Chg | 11.98 M |
| Shares Out | 57.05 M | |
|---|---|---|
| % Shrs Traded | 0.96% | |
| 1yr EPS Est | -0.473 |
| 52-Wk Low | 3.15 | |
|---|---|---|
| 52-Wk High | 10.13 |
|
| Range | 6.98 |
| Prev Close | 8.35 11/20/09 | |
|---|---|---|
| Today's Open | 8.59 | |
| Change | 2.87% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 2.14 M |
| Revenue (LFY) | 27.98 M | |
|---|---|---|
| Earnings (LFY) | -31.94 M | |
| Earnings (MRQ) | -12.38 M | |
| Next Earn Est | -0.207 | |
| Next Earnings | 04/29/2010 |
|
| EPS (TTM) | -0.66 | |
| 1yr EPS Growth | 28.33% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -18.00 | |
| PEG Ratio | — | |
| Return on Equity | -88.88 | |
| Beta | 1.77 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
ImmunoGen is TAPping into cancer research. The firm's product candidates are TAPs, or tumor-activated prodrugs, that combine cancer-killing drugs with monoclonal antibodies and attach only to tumor cells. ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.207 1/28/10 | — — |
—
—
|
| Last Quarter | -0.198 9/30/09 | -0.22 9/30/09 |
-0.022
Missed
|
| 2 Quarters Ago | -0.174 6/30/09 | -0.21 6/30/09 |
-0.036
Missed
|
| Quarterly - 09/30/2009 | Annual - 2009 | |
|---|---|---|
| Total Revenue | 3.10 M | 27.99 M |
| Gross Profit | 8.23 M | 22.99 M |
| Operating Income | -12.68 M | -31.82 M |
| Net Income | -12.38 M | -31.94 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts